International Chemical Investors II

International Chemical Investors Group (ICIG) is a private industrial holding company that specializes in acquiring and managing mid-sized chemical and pharmaceutical businesses. Founded in 2004, the group has built a significant presence in the life sciences sector through its key subsidiaries, most notably CordenPharma, a leading global Contract Development and Manufacturing Organization (CDMO). ICIG focuses on transforming non-core assets from large chemical and pharmaceutical corporations into independent, profitable entities. The group's portfolio spans across fine chemicals, chlor-vinyls, and specialized pharmaceutical manufacturing services, including the production of highly potent APIs, peptides, and lipids for mRNA vaccines. With a global manufacturing footprint, ICIG provides critical infrastructure and supply chain solutions to the global healthcare and industrial sectors.